Conference
Interpretation and Application of the International Myeloma Working Group (IMWG) Criteria: Proposal for Uniform Assessment and Reporting in Clinical Trials Based on the First Study Independent Response Adjudication Committee (IRAC) Experience
Abstract
Abstract
Background: In multiple myeloma (MM), reproducible criteria of disease response and progression are critical to ensuring consistency in trial analysis and reporting.
Authors
Blade J; Knop S; Cohen AD; Shah JJ; Meyer RM
Volume
124
Publisher
American Society of Hematology
Publication Date
December 6, 2014
DOI
10.1182/blood.v124.21.3460.3460
Conference proceedings
Blood
Issue
21
ISSN
0006-4971